Primary Renovascular Effects of Erythromycin in the Rat: Relationship to Cyclosporine Nephrotoxicity

References

• Kohan DE. Possible interaction between cyclosporine and erythromycin. N Engl J Med 1986; 314: 448
   PubMed Web of Science ®Google Scholar
• Ptachcinski R J, Carpenter B J, Burckart G J, Venkatarmanan R, Rosenthal J T. Effect of erythromycin on cyclosporin levels. N Engl J Med 1985; 313: 1416
   PubMed Web of Science ®Google Scholar
• Grino J M, Sabate I, Castelao A M, Guardia M, Seron D, Alsina J. Erythromycin and cyclosporine. Ann Intern Med 1986; 105: 467
   PubMed Web of Science ®Google Scholar
• Martell R, Heinrichs D, Stiller C R, Jenner M, Keown P A, Dupre J. The effects of erythromycin in patients treated with cyclosporine. Ann Intern Med 1986; 104: 660
   PubMed Web of Science ®Google Scholar
• Jensen CWB, Flechner S M, VanBuren C T, Frazier O H, Cooley D A, Lorber M I, Kahan B D. Exacerbation of cyclosporine toxici-ty by concomitant administration of erythromycin. Transplantation 1987; 43: 263
   PubMed Web of Science ®Google Scholar
• Venuto C, Murray B M, Edwards L, Morse G. Cyclosporine-erythormycin drug interaction. Kidney Int 1985; 29: 438, (Abstract.)
   Web of Science ®Google Scholar
• Godin J R, Sketris I S, Belitsky P. Erythromycin-cyclosporine interaction. Drug Intell Clin Pharm 1986; 20: 504
   PubMedGoogle Scholar
• Kessler M, Louis J, Renoult E, Vigneron B, Netter P. Interaction between cyclosporin and erythromycin in a kidney transplant patient. Eur J Clin Pharmacol 1986; 30: 633
   PubMed Web of Science ®Google Scholar
• Gonwa T A, Nghiem D D, Schulak J A, Corry R J. Erythromycin and cyclosporine. Tranplantation 1986; 41: 797
   PubMed Web of Science ®Google Scholar
• Freeman D J, Martell R, Corruthers S G, Heinrichs D, Keown P A, Stiller C R. Cyclosporin-erythromycin interaction in normal subjects. Br J Clin Pharmacology 1987; 23: 776
   PubMed Web of Science ®Google Scholar
• Harnett J D, Parfrey P S, Paul M D, Gault M H. Erythromycin-cyclosporine interaction in renal transplant recipients. Transplantation 1987; 43: 316
   PubMed Web of Science ®Google Scholar
• Vereerstraeten P, Thiry P, Kinnaert P, Toussaint C. Influence of erythromycin on cyclosporine pharmacokinetics. Transplantation 1987; 44: 155
   PubMed Web of Science ®Google Scholar
• Wadhwa N K, Schroeder T J, O'Flaherty E, Pesce A J, Myre S A, Munda R, First M R. Interaction between erythromycin and cyclosporine in a kidney and pancreas allograft recipient. Ther Drug Monit 1987; 9: 123
   PubMed Web of Science ®Google Scholar
• Whiting P H, Burke M D, Thomson A W. Drug interactions with cyclosporine: Implications from animal studies. Transplant Proc 1986; 18(Suppl 5)56
   PubMed Web of Science ®Google Scholar
• Ben-Ari J, Eisenstein B, Davidovits M, Shmueli D, Shapira Z, Stark H. Effect of erythromycin on blood cyclosporine concentrations in kidney transplant patients. J Pediatrics 1988; 112: 992
   PubMed Web of Science ®Google Scholar
• Matas A J, Simmons R L, Kjellstrand C M, Majarian J S. Pseudore-jection: Factors mimicking rejection in renal allograft recipients. Ann Surg 1979; 186: 51
   Web of Science ®Google Scholar
• Sullivan B A, Hak L J, Finn W F. Cyclosporine nephrotoxicity: studies in laboratory animals. Transplant Proc 1985; 17(Suppl 1)145
   PubMed Web of Science ®Google Scholar
• Murray B M, Paller M S, Ferris T F. Effect of acute and chronic cyclosporine administration on renal hemodynamics in conscious rats. Kidney lnt 1985; 28: 767
   PubMed Web of Science ®Google Scholar
• Finn W F, McCormack A J, Sullivan B A, Hak L J, Clark R L. Influence of the rate of infusion on cyclosporine nephrotoxicity in the rat. Renal Failure 1989; 11: 3
   PubMed Web of Science ®Google Scholar
• Arendshorst W J, Finn W F, Gottschalk C W. Autoregulation of blood flow on the rat kidney. Am J Physiol 1975; 228: 127
   PubMed Web of Science ®Google Scholar
• Rosenfeld J, Gura V, Boner G, Ben-Bassat M, Livni E. Interstitial nephritis with acute renal failure after erythromycin. Br Med J 1983; 286: 938
   PubMed Web of Science ®Google Scholar
• Linton A L, Clark M F, Driedger A A, Turnbull D I, Linksay R M. Acute interstitial nephritis due to drugs. Review of the literature, report of nine cases. Ann Intern Med 1980; 93: 735
   PubMed Web of Science ®Google Scholar
• Handa SP. The Schonlein-Henoch Syndrome: Glomerulonephritis following erythromycin. Southern Med J 1972; 65: 917
   PubMed Web of Science ®Google Scholar
• Ludden TM. Pharmacokinetic interactions of the macrolide antibiotics. Clin Pharmacokinetics 1985; 10: 63
   PubMed Web of Science ®Google Scholar
• Haydon R C, Thelin J W, Davis W E. Erythromycin ototoxicity: Analysis and conclusions based on 22 case reports. Otolaryngol Head Neck Surg 1984; 92: 678
   PubMed Web of Science ®Google Scholar
• Siegl H, Ryffel B, Petric R, Shoemaker P, Muller A, Donatsch P, Mihatsch M. Cyclosporine, the renin-angiotensin system and renal adverse reactions. Transplant Proc 1 1983; 5(Suppl. 1)2719
   Google Scholar
• Moss N G, Powell S L, Falk R J. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci USA 1985; 82: 8222
   PubMed Web of Science ®Google Scholar
• Heys S D, Stephen M S, Duncan J I, Whiting P H. CsA nephrotox-icity: Effects of renal denervation in the nontransplanted and transplanted rat kidney. Renal Failure 1989; 11: 263
   Google Scholar
• Goto T, Kino T, Hatanaka H, Nishiyama M, Okuhara M, Kohsaka M, Aoki H, Imanaka H. Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc 1987; 19(Suppl 6)4
   PubMed Web of Science ®Google Scholar
• Todo S, Demetris A J, Ueda Y, Imventarza O, Okuda K, Casavilla A, Cemaj S, Ghalab A, Mazzaferro V, Rhoe B S, Tonghua Y, Makawka L, Starzl T E. Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc 1987; 19(Suppl 6)57
   PubMed Web of Science ®Google Scholar
• Thomson A W, Stephen M E, Woo J, Hasan N U, Whiting P H. Im-munosuppressive activity, T-cell subset analysis, and acute tox-icity of FK-506 in rats. Transplant Proc 1989; 21: 1048
   PubMed Web of Science ®Google Scholar
• Nalesnik M A, Lai H S, Murase N, Todo S, Starzl T E. The effect of FK 506 and CyA on the Lewis rat renal ischemia model. Transplant Proc 1990; 22(Suppl 1)87
   PubMed Web of Science ®Google Scholar
• McCauley J, Jung J, Jain A, Todo S, Starzl T E. The effects of FK-506 on renal function after liver transplantation. Transplant Proc 1990; 22(Suppl 1)17
   PubMed Web of Science ®Google Scholar